Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESRX
251
DELISTED
Express Scripts Holding Company
ESRX
| $50.9M | 0.1% |
572,617
-36,607
| -6% | -$3.2M |
|
252
Vertex Pharmaceuticals
VRTX
$139B
| $50.8M | 0.1% |
411,636
+322,607
| +362% | +$40.7M |
|
|
DD
253
DELISTED
Du Pont De Nemours E I
DD
| $50.5M | 0.1% |
832,010
+818,368
| +5,999% | +$55.1M |
|
|
AKRX
254
DELISTED
Akorn Inc
AKRX
| $50.5M | 0.1% |
1,155,869
+321,277
| +38% | +$14.9M |
|
255
Portland General Electric
POR
$5.83B
| $50.3M | 0.1% |
1,518,364
+945,667
| +165% | +$33.2M |
|
|
WLL
256
DELISTED
Whiting Petroleum Corporation
WLL
| $50.3M | 0.1% |
4,994
-11,612
| -70% | -$121M |
|
257
CBRE Group
CBRE
$44B
| $50.1M | 0.09% |
1,354,627
-291,216
| -18% | -$11.1M |
|
258
Cheniere Energy
LNG
$57.3B
| $49.9M | 0.09% |
720,621
-295,130
| -29% | -$22.1M |
|
259
Royal Bank of Canada
RY
$285B
| $49.8M | 0.09% |
+814,478
| New | +$52.4M |
|
260
Energy Transfer Partners
ET
$73B
| $49.7M | 0.09% |
1,550,342
+334,352
| +27% | +$11.2M |
|
261
Ultragenyx Pharmaceutical
RARE
$2.55B
| $49.6M | 0.09% |
484,180
-497,666
| -51% | -$38.6M |
|
262
Groupon
GRPN
$797M
| $49.4M | 0.09% |
490,872
+42,217
| +9% | +$5.45M |
|
263
Arthur J. Gallagher & Co
AJG
$67.6B
| $49.3M | 0.09% |
1,043,210
+511,474
| +96% | +$24.6M |
|
264
AbbVie
ABBV
$468B
| $48.7M | 0.09% |
725,312
-85,766
| -11% | -$5.6M |
|
265
Equinix
EQIX
$105B
| $48.4M | 0.09% |
190,571
+55,287
| +41% | +$14.1M |
|
|
COR
266
DELISTED
Coresite Realty Corporation
COR
| $48.2M | 0.09% |
1,060,657
+577,995
| +120% | +$27.6M |
|
267
Costco
COST
$420B
| $48.2M | 0.09% |
+356,574
| New | +$51.3M |
|
|
MRD
268
DELISTED
MEMORIAL RESOURCE DEV CORP COM STK (DE)
MRD
| $48M | 0.09% |
2,531,516
-5,824,179
| -70% | -$112M |
|
|
DCT
269
DELISTED
DCT Industrial Trust Inc.
DCT
| $47.8M | 0.09% |
1,520,199
+51,220
| +3% | +$1.7M |
|
270
Clearway Energy Class C
CWEN
$6.68B
| $47.7M | 0.09% |
2,180,873
+560,259
| +35% | +$14.1M |
|
271
Alaska Air
ALK
$4.51B
| $47.6M | 0.09% |
+739,339
| New | +$47.6M |
|
272
Alphabet (Google) Class C
GOOG
$4.18T
| $47.4M | 0.09% |
1,784,260
-73,627
| -4% | -$1.97M |
|
273
Ashland
ASH
$3.33B
| $47.1M | 0.09% |
790,464
+712,951
| +920% | +$44.4M |
|
274
Western Digital
WDC
$166B
| $47.1M | 0.09% |
794,733
+47,889
| +6% | +$3.43M |
|
275
Genuine Parts
GPC
$18.5B
| $46.9M | 0.09% |
524,219
-262,484
| -33% | -$24.2M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.